Viral Keratitis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis (NCT04560790) | Shanghai BDgene Co., Ltd. | 2020-11-04 |
Track Viral Keratitis automatically
Every clearance here is in the API, with alerts when new ones post.